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OBJECTIVES The relation between the occurrence of pacing-induced mechanical alternans and prognosis
in patients with mild-to-moderate idiopathic dilated cardiomyopathy (IDCM) in sinus
rhythm was investigated prospectively. The myocardial expression of genes for Ca2-
handling proteins in such patients was also examined.
BACKGROUND Mechanical alternans occurs in some patients with severe heart failure, but the relation
between the occurrence of mechanical alternans and prognosis in patients with IDCM has
remained unknown.
METHODS Left ventricular (LV) pressure was measured during atrial pacing, and LV endomyocar-
dial biopsy specimens were collected in 36 IDCM patients and 8 controls. Idiopathic
dilated cardiomyopathy patients were divided into two groups consisting of 22 individuals
who did not develop mechanical alternans at heart rates up to 140 beats/min (group A)
and of 14 individuals who did (group B). The patients were followed up for a mean of 3.7
years.
RESULTS There was no significant difference in LV ejection fraction or the plasma concentration of
brain natriuretic peptide between groups A and B. The myocardial abundance of ryanodine
receptor 2 messenger ribonucleic acid (mRNA) was significantly lower in groups A and B
than in controls, whereas that of sarcoplasmic reticulum Ca2-ATPase mRNA was
significantly lower in group B than in group A or controls. Stepwise multivariate analysis
identified pacing-induced mechanical alternans as the strongest predictor of cardiac events.
Event-free survival in group A was significantly greater than that in group B.
CONCLUSIONS The occurrence of pacing-induced mechanical alternans is a potentially useful indicator of
poor prognosis in patients with mild-to-moderate IDCM in sinus rhythm. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.10.069Cardiol 2006;47:1382–9) © 2006 by the American College of Cardiology Foundation
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sdiopathic dilated cardiomyopathy (IDCM) is characterized
y progressive left ventricular (LV) dilation and greatly
mpaired LV systolic function, eventually culminating in
nd-stage congestive heart failure (CHF) and cardiac death
1,2). It is therefore important to identify as early as possible
atients with IDCM who are unlikely to improve or
tabilize in response to standard medical treatment. Several
tudies have attempted to find clinical or other abnormali-
ies associated with poor prognosis in such individuals.
arkers examined have included indexes related to LV
ystolic or diastolic function, such as LV ejection fraction
LVEF), LV end-diastolic dimensions and pressures, and
he plasma concentration of brain natriuretic peptide (BNP)
2–6). However, LVEF is load-dependent, and plasma
NP level is affected by changes in LV wall stress during
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005, accepted October 25, 2005.reatment (7–9), properties that may limit their predictive
alue. Furthermore, the plasma concentration of BNP has
een found to be less accurate for detection of milder
egrees of systolic dysfunction (10), which are more com-
on than are severe forms but are also associated with
ncreased risk of mortality.
Mechanical alternans has been detected in both patients
ith severe heart failure and animal models of this condition
11–13). Although rare under resting conditions in individ-
als with controlled heart failure (14), mechanical alternans
s more prevalent and likely to be sustained at higher heart
ates (15). The relation between the occurrence of mechan-
cal alternans and the prognosis of patients with IDCM has
ot previously been examined, however.
Atrial fibrillation is common in patients with IDCM and
s associated with a variety of potentially deleterious hemo-
ynamic consequences that might exert a negative influence
n prognosis and accelerate the progression of LV systolic
ysfunction (16). The overall survival rate for patients in
inus rhythm is higher than that for patients with atrial
brillation (16,17). However, prognostic indicators for pa-
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April 4, 2006:1382–9 Mechanical Alternans and Prognosis of IDCMients with mild-to-moderate IDCM in sinus rhythm re-
ain unclear. We have therefore now examined prospec-
ively the prognostic value of pacing-induced mechanical
lternans in patients with mild-to-moderate IDCM in sinus
hythm.
ETHODS
ubjects. We studied 36 patients with mild-to-moderate
DCM (mean age, 49 years; range, 32 to 62 years), 26 of
hom had previously been admitted to hospital because of
eart failure with dyspnea on exertion, palpitations, or
eripheral edema. The remaining 10 patients were asymp-
omatic and were identified on the basis of an electrocar-
iogram abnormality at an annual health check. The IDCM
f the patients was defined as mild-to-moderate on the basis
f clinical symptoms.
All patients showed a normal sinus rhythm; IDCM was
efined on the basis of the presence of both a reduced
VEF (50% as determined by contrast left ventriculogra-
hy) and a dilated LV cavity in the absence of coronary or
alvular heart disease, arterial hypertension, or cardiac muscle
isease caused by any known systemic condition (18). None of
he patients had an identifiable family history of dilated
ardiomyopathy in a second-degree relative. The 26 patients
ho had previously been hospitalized for acute heart failure
ere receiving treatment and were in stable condition before
heir referral to Nagoya University Hospital for cardiac
atheterization. The period that elapsed between hospital-
zation and catheterization averaged 4.0 months (range, 2 to
months).
The control subjects consisted of eight individuals under-
oing diagnostic cardiac catheterization for evaluation of
typical chest pain and a mild ST-T abnormality on their
lectrocardiograms. All control subjects manifested normal
chocardiograms, coronary arteriograms, and contrast ven-
riculograms. Endomyocardial biopsies were also performed
o exclude myocarditis or specific heart muscle disease, and
ll control subjects had normal pathological findings. The
tudy protocol was approved by the appropriate institutional
eview committee, and written informed consent was ob-
Abbreviations and Acronyms
BNP  brain natriuretic peptide
CHF  congestive heart failure
GAPDH  glyceraldehyde-3-phosphate
dehydrogenase
IDCM  idiopathic dilated cardiomyopathy
LV  left ventricle or left ventricular
LVdP/dtmax  maximal first derivative of LV pressure
LVEF  left ventricular ejection fraction
mRNA  messenger ribonucleic acid
RT-PCR  reverse transcription-polymerase chain
reaction
SERCA2  sarcoplasmic reticulum Ca2-ATPase
T1/2  pressure half-timeained from all subjects. mardiac catheterization. A 6-F fluid-filled pigtail catheter
ith a high-fidelity micromanometer (model SPC-464D,
illar Instruments, Houston, Texas) was advanced into the
V through the right femoral artery for measurement of LV
ressure. A 6-F bipolar pacing catheter was introduced
hrough the right femoral vein and positioned in the right
trium. Right atrial pacing was initiated at 80 beats/min and
ncreased in increments of 10 beats/min. Micromanometer
ressure signals and standard electrocardiograms were re-
orded with a multichannel recorder (MR-40, TEAC,
okyo, Japan) throughout the procedure. Left ventricular
ressure signals were digitized at 3-ms intervals and ana-
yzed with a 32-bit microcomputer system and software
eveloped in-house. We selected steady-state LV pressure
ata at the baseline and at each pacing rate for analysis. We
alculated the maximal first derivative of LV pressure (LV
P/dtmax) as an index of contractility. To evaluate LV
sovolumic relaxation, we computed the pressure half-time
T1/2) directly as previously described (19). The peak pacing
ate was defined as the heart rate at which second-degree
trioventricular block occurred. After completion of the
acing study, selective coronary angiography as well as left
entriculography was performed. Endomyocardial biopsy was
lso performed in all patients to exclude myocarditis or specific
eart muscle disease. Several (at least three) endomyocardial
iopsy specimens were obtained from the free wall of the LV.
iopsy samples for messenger ribonucleic acid (mRNA) anal-
sis were frozen immediately in liquid nitrogen and stored at
80°C until use.
uantitative reverse transcription-polymerase chain
eaction (RT-PCR) analysis. Quantitative RT-PCR anal-
sis of the amounts of the mRNAs for glyceraldehyde-3-
hosphate dehydrogenase (GAPDH), sarcoplasmic reticu-
um Ca2-ATPase (SERCA2), ryanodine receptor 2,
hospholamban, calsequestrin, and the Na-Ca2 ex-
hanger was performed with a Prism 7700 Sequence De-
ector (Perkin-Elmer, Foster City, California) as previously
escribed (20). Variability in the efficiency of cDNA syn-
hesis was corrected by dividing the levels of Ca2-handling
rotein mRNAs by that of GAPDH mRNA.
tudy protocol. To evaluate whether the rate of cardiac
vents differed between patients with or without pacing-
nduced mechanical alternans, we prospectively followed up
ll patients for the occurrence of primary events, which were
efined as cardiac death (from worsening CHF or sudden
eath) or the unscheduled readmission for decompensated
HF. Noncardiac death was excluded.
tatistical analysis. Data are presented as means  SD.
aseline characteristics and hemodynamic variables were
ompared among groups by one-way factorial analysis of
ariance; if a significant difference was detected, intergroup
omparisons were performed with Scheffe’s multiple-
omparison test. Reverse transcription-polymerase chain reac-
ion analysis of the abundance of Ca2-handling protein
RNAs among groups were also compared by one-way
f
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Mechanical Alternans and Prognosis of IDCM April 4, 2006:1382–9actorial analysis of variance if a significant difference was
etected. Within-group comparisons for changes in hemo-
ynamic variables between baseline and 120 beats/min of
trial pacing were performed with the paired Student t test.
omparisons between measurements from the strong and
eak beats of mechanical alternans were also performed
ith the paired Student t test. Cox proportional hazard
egression analysis was performed to identify independent
redictors of cardiac events. We also performed a stepwise
orward selection procedure. Cumulative cardiac event esti-
ates were calculated by the Kaplan-Meier method; differ-
nces between the survival curves were assessed by the
og-rank test. All analyses were performed with the SPSS
2.0 software package (SPSS Inc., Chicago, Illinois). A
value of 0.05 was considered statistically significant.
ESULTS
lassification of IDCM patients based on mechanical
lternans. Mechanical alternans was diagnosed if the pres-
ure difference between the strong and weak beats was 4
m Hg. Under baseline conditions, no patient exhibited
echanical alternans. We divided the IDCM patients into
wo groups on the basis of the absence or presence of
igure 1. Representative records of pacing-induced mechanical alternans.
ressure, and LV dP/dt at a baseline heart rate (HR) of 66 beats/min (bp
ardiomyopathy. Alternating pressure was 30 mm Hg at the pacing rate of
V pressure. dP/dt  first derivative of left ventricular pressure.acing-induced mechanical alternans. Group A consisted of t2 IDCM patients who did not develop mechanical alter-
ans at heart rates up to 140 beats/min, whereas group B
omprised 14 IDCM patients who did. The average heart
ate at which mechanical alternans appeared (critical pacing
eart rate) in IDCM patient group B was 99  10
eats/min. Waveforms at baseline and 120 beats/min of
acing for a representative male IDCM patient with pacing-
nduced mechanical alternans are shown in Figure 1.
aseline clinical data. Baseline clinical characteristics for
he control group and IDCM patient groups A and B are
hown in Table 1. There were no significant differences in
ge or sex among the three study groups. All IDCM
atients were classified as New York Heart Association
unctional class I or II at the time of cardiac catheterization.
f the 36 IDCM patients, 12 had been treated previously
ith digitalis, 28 with diuretics, 26 with angiotensin-
onverting enzyme inhibitors or angiotensin-II receptor block-
rs, and 19 with beta-blockers. There were no signifcant
ifferences in drug treatment at entry into the study between
atient groups A and B. There was also no significant
ifference in LVEF between groups A and B. The LV
nd-diastolic and end-systolic volumes were both signifi-
antly increased in IDCM patient group B compared with
traces represent a lead II electrocardiogram (ECG), left ventricular (LV)
d at atrial pacing of 120 bpm for a male patient with idiopathic dilated
pm. Both LV dP/dtmax and LV dP/dtmin showed alternating changes withThe
m) anhose in group A. The plasma BNP level tended to be
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April 4, 2006:1382–9 Mechanical Alternans and Prognosis of IDCMigher in group B than in the control group or in group A,
ut these differences were not significant.
Given that 10 of the 22 patients in group A and 6 of the
4 patients in group B could not achieve a heart rate of
130 beats/min because of Wenckebach block, we com-
ared hemodynamic variables at baseline with those at 120
eats/min of pacing (Table 2). There was no significant
ifference in LV peak-systolic pressure or LV end-diastolic
ressure at baseline among the three groups of subjects;
DCM patients exhibited a lower LV dP/dtmax and a longer
1/2 than did controls at baseline. There was no significant
ifference in LV dP/dtmax or T1/2 between patient groups A
nd B at baseline.
bundance of Ca2-handling protein mRNAs in endo-
yocardial biopsy specimens. The amounts of Ca2-
andling protein mRNAs in endomyocardial biopsy speci-
ens were determined by RT-PCR analysis and were
ormalized relative to that of GAPDH mRNA (Table 3).
he abundance of SERCA2 mRNA in the LV myocardium
as significantly reduced in patient group B compared with
hat in patient group A or in the control group. The amount
f ryanodine receptor 2 mRNA was significantly reduced in
atient groups A and B compared with that in the control
roup. No significant differences in the levels of phospho-
amban, calsequestrin, or Na-Ca2 exchanger mRNAs or
n the SERCA2/Na-Ca2 exchanger mRNA ratio were
pparent among the three groups.
nivariate and multivariate analysis of cardiac events. Uni-
Table 1. Baseline Clinical Characteristics
Characteristics
Con
(n 
Age (yrs) 45 
Gender (M/F) 8
NYHA functional class
I
II
Prior treatment
Digitalis 0
Diuretics 0
ACE inhibitors or AR blockers 0
Beta-blockers 0
LV end-diastolic dimension (mm) 49 
LV end-systolic dimension (mm) 31 
IVS thickness (mm) 10 
LVPW thickness (mm) 10 
LV mass index (g/m2) 131 
LV end-diastolic volume (ml) 133 
LV end-systolic volume (ml) 40 
LVEF (%) 66 
PAWP (mm Hg) 8 
Cardiac index (l min1 m2) 3.36 
Plasma BNP (pg/ml) 6 
*p  0.01 vs. controls; †p  0.01 vs. group A; ‡p  0.05 v
ACE  angiotensin-converting enzyme; AR  angiotensin-
dilated cardiomyopathy; IVS interventricular septum; LV l
wall; NYHA  New York Heart Association; PAWP  pulmariate analysis revealed that pacing-induced mechanical alternans, heart rate, LV end-diastolic pressure, the ratio of
V end-diastolic pressure to cardiac index, and LVEF were
ignificant predictors of cardiac events (Table 4). These vari-
bles were then subjected to stepwise multivariate analysis,
ielding only pacing-induced mechanical alternans as a signif-
cant independent predictor of cardiac events.
vent-free survival. The cumulative probability of
vent-free survival was calculated by the Kaplan-Meier
ethod (Fig. 2). All patients with IDCM were followed
or an average of 3.7 years (range, 0.8 to 7.5 years)
tarting at the time of catheterization and ending with a
ardiac event or the most recent evaluation of survivors.
wo patients (one in each of groups A and B) were
xcluded from this analysis because they died of noncar-
iac causes. Cardiac death occurred in one patient in
roup A and two patients in group B. One patient in
roup A experienced CHF. Six patients in group B
xperienced cardiac events, classified as CHF in five and
yncope in one. The three-year cumulative probabilities
f event-free survival were 88.1% in group A and 40.4%
n group B. The probability of event-free survival in
roup A was significantly higher than that in group B by
he log-rank test.
ISCUSSION
e have shown that the occurrence of pacing-induced
echanical alternans was a predictor of poor prognosis in
atients with mild-to-moderate IDCM in sinus rhythm,
IDCM
Group A
(n  22)
Group B
(n  14)
48  13 51  12
20/2 11/3
13 (59%) 6 (43%)
9 (41%) 8 (57%)
6 (27%) 6 (43%)
16 (73%) 12 (86%)
17 (77%) 9 (64%)
10 (45%) 9 (64%)
61  8* 69  9*†
50  8* 58  9*†
9  2 9  1
9  2 9  1
142  57 172  48
170  59 253  112*†
108  50 184  90*†
37  9* 33  8*
9  4 16  9‡§
2.93  0.49 2.70  0.92
68  69 98  116
rols; §p  0.05 vs. group A.
ptor; BNP  brain natriuretic peptide; IDCM  idiopathic
tricular; LVEF LV ejection fraction; LVPW LV posterior
arterial wedge pressure.trols
8)
12
/0
5
5
2
2
38
45
21
8
3
1.41
3
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II recend that the abundance of SERCA2 mRNA in LV endo-
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Mechanical Alternans and Prognosis of IDCM April 4, 2006:1382–9yocardial biopsy specimens was decreased in IDCM
atients with pacing-induced mechanical alternans com-
ared with that in those without it.
Despite recent improvements in the medical management
f patients with IDCM, the overall prognosis of such
ndividuals remains poor, with heart transplantation often
eing the only lifesaving therapeutic option (1,2,6). Even in
atients with mild-to-moderate IDCM, sudden death oc-
asionally occurs or hospitalization is needed for worsening
eart failure. It has been difficult to predict such outcomes,
owever. Although several studies have attempted to iden-
ify prognostic factors for a poor outcome in patients with
DCM, none has revealed a factor proven to predict unequiv-
cally the risk of cardiac events. Our present study is thus the
rst to show that the occurrence of pacing-induced mechan-
cal alternans is a potential independent clinical predictor of
able 2. Hemodynamic Variables at Baseline and at a Heart Rat
p  0.01 vs. controls; †p  0.01 vs. group A; ‡p  0.01 vs. strong beat at 120 bea
LV dP/dtmax  maximal first derivate of left ventricular pressure; LVEDP  left vent
alf-time.
Table 3. RT-PCR Analysis of the Abundance
(Normalized by the Amount of GAPDH mRN
mRNA Ratio Contr
SERCA2/GAPDH 1.24 
Phospholamban/GAPDH 2.01 
Ryanodine receptor 2/GAPDH 1.45 
Calsequestrin/GAPDH 2.26 
Na-Ca2 exchanger/GAPDH 2.68 
SERCA2/Na-Ca2 exchanger 0.87 
*p  0.05 vs. controls; †p  0.05 vs. group A.
GAPDH  glyceraldehyde-3-phosphate dehydrogenase; RT-
SERCA2  sarcoplasmic reticulum Ca2-ATPase.ardiac events in patients with mild-to-moderate IDCM in
inus rhythm.
acing-induced mechanical alternans. We have shown
hat the amount of SERCA2 mRNA in LV endomyocar-
ial biopsy specimens was decreased in IDCM patients with
acing-induced mechanical alternans compared with that in
uch patients without pacing-induced mechanical alternans,
hereas the amount of ryanodine receptor 2 mRNA was
ignificantly reduced in both patient groups compared with
hat in the control group. Because of the difficulty in
btaining appropriate specimens, few studies have investi-
ated the cellular mechanism of mechanical alternans in the
ntact human heart. A reduction in the amounts of both
ERCA2 and ryanodine receptor 2 mRNAs was previously
escribed in humans with end-stage dilated cardiomyopathy
t the time of heart transplantation (21,22).
20 Beats/min During Pacing
; §p  0.01 vs. baseline; p  0.05 vs. group A; ¶p  0.05 vs. controls.
end-diastolic pressure; LVPSP  left ventricular peak systolic pressure; T1/2  pressure
a2-Handling Protein mRNAs
in Endomyocardial Biopsy Specimens
Group A Group B
0.50  0.12* 0.30  0.13*†
2.13  0.80 1.84  0.19
0.48  0.16* 0.54  0.34*
1.61  0.89 1.61  1.25
0.99  0.84 1.37  1.02
1.20  1.25 0.30  0.20e of 1
ts/minof C
A)
ols
0.18
0.69
0.26
1.75
2.29
0.65PCR  reverse transcription-polymerase chain reaction;
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April 4, 2006:1382–9 Mechanical Alternans and Prognosis of IDCMWhether abnormal expression of the SERCA2 gene is
esponsible for mechanical alternans remains unclear. The
resence of a delay between the uptake of Ca2 into the
arcoplasmic reticulum and its subsequent release has been
roposed to account for mechanical alternans (23–25). Our
RNA measurements do not directly reflect the Ca2
ptake and Ca2 release activities of sarcoplasmic reticulum
n the myocardium. However, our data suggest that a
ecrease in the abundance of mRNAs for proteins that
ediate Ca2 uptake (SERCA2) or Ca2 release (ryano-
ine receptor 2) might result in a reduction in the relative
umber of excitation-contraction coupling sites and in
onsequent dysregulation of Ca2 handling by the sarco-
lasmic reticulum in the failing myocardium. Such abnor-
al Ca2 handling might substantially alter the force-
requency relation and myocardial performance.
omparison with previous studies. Outcome can be im-
roved in high-risk patients with CHF by treatment inten-
ification and home-based interventions (7,26). However,
here is currently no simple clinical criterion or score for
redicting short-term outcome after discharge and thus for
dentifying patients for whom extra caution is required.
Plasma BNP level has been suggested to be a strong,
ndependent predictor of cardiac events and sudden death in
atients with CHF (27,28). A high plasma concentration of
NP before discharge was reported to be a powerful,
ndependent marker of death or readmission in patients
ith decompensated CHF (7,29,30); BNP is thus now
idely used as a clinical marker for differential diagnosis and
anagement of heart failure. Patients with plasma BNP
evels that do not correlate with the severity of their heart
ailure are encountered not infrequently, however. Several
able 4. Univariate and Multivariate Predictors of Cardiac Event
U
Event-Free Group
(n  24)
roup A/group B 19/5
ge (yrs) 47  13
ender (M/F) 22/2
V end-diastolic dimension (mm) 63  10
V end-systolic dimension (mm) 51  10
V end-diastolic volume (ml) 195  95
V end-systolic volume (ml) 129  79
VEF (%) 38  9
AWP (mm Hg) 10  6
ardiac index (l min1 m2) 3.04  0.66
lasma BNP (pg/ml) 75  78
eart rate (beats/min) 74  14
V peak-systolic pressure (mm Hg) 121  16
V end-diastolic pressure (mm Hg) 11  7
VEDP/cardiac index (mm Hg min m2 l1) 3.83  2.99
V dP/dtmax (mm Hg/s) 1,266  256
eak change in LV dP/dtmax (%) 110  11
1/2 (ms) 40  8
ignificant p values are shown in bold for univariate analysis.
CI  confidence interval; LVEDP  left ventricular end-diastolic pressure; OR  otudies have suggested that BNP is substantially less accu-
p
sate for detection of milder degrees of systolic dysfunction
10), which are more common than are severe forms but are
lso associated with increased risk. Additional studies are
eeded to define optimal therapy for mild asymptomatic LV
ystolic dysfunction (31).
Left ventricular ejection fraction has also been suggested
s an independent prognostic factor (27,32,33). An LVEF
f 20% was thus found to be associated with a one-year
ortality of 30% in patients with dilated cardiomyopathy (4).
owever, other studies either did not support this finding
34,35) or showed that LVEF was less predictive than were
ther parameters such as transmitral inflow characteristics
igure 2. Cumulative probability of event-free survival calculated by the
aplan-Meier method for all idiopathic dilated cardiomyopathy patients and
DCM Patients
riate Analysis Multivariate Analysis
ardiac-Event Group
(n  10) p Value OR (95% CI) p Value
2/8 0.004 6.18 (1.31–29.2) 0.021
52  12 0.366
7/3 0.276
66  7 0.290
56  7 0.139
224  97 0.442
161  81 0.295
31  7 0.032
18  10 0.077
2.57  0.74 0.143
238  217 0.131
91  19 0.005
112  22 0.147
18  10 0.021
7.91  5.32 0.043
1,103  208 0.083
112  8 0.727
43  9 0.401
tio; PAWP  pulmonary arterial wedge pressure. Other abbreviations as in Table 1.s in I
niva
Catient groups A and B. The probability of event-free survival in group A was
ignificantly greater than that in group B by the log-rank test (p  0.021).
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Mechanical Alternans and Prognosis of IDCM April 4, 2006:1382–95). A limitation of these markers, however, is their load
ependence, which may confound accurate assessment of
V systolic or diastolic function and limit their predictive
alue (36).
The patients in our study were ambulatory, had a mean
VEF of 35%, and were in sinus rhythm. They were all of
ew York Heart Association functional class I or II,
hereas most previous studies have been based on pa-
ients of class III or IV. In addition, most previous
tudies have included patients with atrial fibrillation. The
resence of atrial fibrillation with heart failure has been
hown to be independently associated with an increased
isk for mortality (16).
Our prospective study constitutes the first demonstra-
ion that the occurrence of pacing-induced mechanical
lternans is a potentially important and independent
rognostic predictor in clinically stable and ambulatory
atients with mild-to-moderate IDCM in sinus rhythm.
ur results support the notion that assessment of con-
ractile reserve and of responses to physiological stress in
he myopathic heart provides important prognostic and
athophysiological insight over and above that derived
nder baseline conditions. For patients with IDCM,
specially those in whom cardiac catheterization is per-
ormed for diagnosis, examination for the occurrence of
acing-induced mechanical alternans may thus provide
rognostic information in addition to that based on
VEF or plasma BNP concentration.
linical implications and study limitations. The preva-
ence of cardiac events or cardiac death was higher in the
atients with pacing-induced mechanical alternans than in
hose without it in the present study. Our results should
herefore facilitate the clinical identification of patients with
n increased mortality and morbidity risk, as well as prove
elpful in the design of future trials examining mortality in
ndividuals with mild-to-moderate IDCM. Assessment of
acing-induced mechanical alternans in addition to routine
linical evaluation in patients with mild-to-moderate
DCM may thus contribute to stratification of patients into
ow- or high-risk groups.
The identification of pacing-induced mechanical alter-
ans requires an invasive examination. This condition is
herefore not amenable to repeated assessment over time,
ossibly representing a limitation of its prognostic utility.
he small number of patients enrolled in the present study
nd the limited number of variables tested for prognostic
erit also represent limitations to the generalizability of its
ndings. Further studies with larger numbers of subjects
ill thus be needed to confirm our present results.
onclusions. The occurrence of pacing-induced mechan-
cal alternans was demonstrated to be a potentially useful
linical predictor of poor prognosis in patients with mild-
o-moderate IDCM in sinus rhythm. The myocardial abun-
ance of SERCA2 mRNA was decreased in patients with
acing-induced mechanical alternans compared with that in
hose without it. Whether these findings will also hold for
2atients with more severe heart failure requires further
nvestigation.
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